A short peptide protects from age-onset proteotoxicity

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Aberrant protein aggregation is a hallmark of neurodegenerative diseases like Alzheimer's (AD) and Huntington's (HD).
• Developing therapeutics to mitigate the toxicity of these protein aggregates is a significant challenge.

Purpose of the Study:

• To investigate the neuroprotective potential of a five-amino acid peptide (5MER) derived from CD44.
• To determine if the 5MER peptide can protect model nematodes from the toxicity of amyloid-beta (Aβ) and poly-glutamine (polyQ) protein aggregates.

Main Methods:

• Treatment of model nematodes with the 5MER peptide.
• Assessment of peptide toxicity on Aβ and polyQ-induced neurodegeneration.
• Analysis of lifespan, aggregation, gene expression, and proteostasis pathways.
• Knockdown of specific genes (e.g., txt-13) to elucidate mechanisms.

Main Results:

• The 5MER peptide significantly reduced the toxicity of both Aβ and polyQ aggregates in nematodes.
• Protection was dependent on aging-related transcription factors and correlated with increased aggregation.
• Transcriptomic analysis revealed modulation of protein homeostasis (proteostasis) pathways, including txt-13 and proteasome activity.
• Knockdown of txt-13 mimicked the protective effects of the 5MER peptide, suggesting activation of transcellular chaperone signaling.

Conclusions:

• The 5MER peptide demonstrates significant neuroprotective effects against protein aggregate toxicity relevant to AD and HD.
• The peptide likely functions by enhancing proteostasis through pathways involving txt-13 and transcellular chaperone signaling.
• The 5MER peptide represents a potential therapeutic candidate for neurodegenerative diseases.